Basit öğe kaydını göster

dc.contributor.authorUnal, Seher N.
dc.contributor.authorTaser, Omer
dc.contributor.authorSanfi, Yasemin
dc.contributor.authorZulrikar, Bulent
dc.contributor.authorPalanduz, Sukru
dc.contributor.authorCefle, Kivanc
dc.contributor.authorKilicoglu, Önder İsmet
dc.contributor.authorTurkmen, Cuneyt
dc.contributor.authorOzturk, Sukru
dc.date.accessioned2021-03-04T08:14:17Z
dc.date.available2021-03-04T08:14:17Z
dc.date.issued2007
dc.identifier.citationTurkmen C., Ozturk S., Unal S. N. , Zulrikar B., Taser O., Sanfi Y., Cefle K., Kilicoglu Ö. İ. , Palanduz S., "The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid", CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, cilt.22, sa.3, ss.393-399, 2007
dc.identifier.issn1084-9785
dc.identifier.othervv_1032021
dc.identifier.otherav_6242a551-ac49-4a4b-b332-43490338bef2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/68446
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34447579952&origin=inward
dc.identifier.urihttps://doi.org/10.1089/cbr.2006.328
dc.description.abstractThe aim of this study was to investigate the genotoxic effect on the peripheral blood lymphocytes potentially induced by yttrium-90 citrate colloid (Y-90) in children who were undergoing radiosynovectomy for hemophilic synovitis, using chromosomal aberration analysis (CA) and the micronuclei (MN) assay for detecting chromosomal aberrations, as well as the sister chromatid exchanges (SCE) technique for assessed DNA damage. Materials and Methods: Cytogenetic analyses were undertaken in 18 boys (mean age, 14.5 +/- 2.1 years) with hemophilic synovitis who underwent radiosynovectomy with Y-90. CA, MN, and SCE were evaluated just prior to, then at 2 and 90 days following radiosynovectomy from the peripheral lymphocytes of the children. An activity of 185 MBq of Y-90 was injected into the 18 knee joints under aseptic conditions. To check the possibility of leakage from the joint and its migration within the body, the patients underwent scanning under a dual-headed gamma camera at the hours 2 and 48 following the procedure. Results: The procedure was well tolerated in all the children, and there was no extra-articular activity owing to extraarticular leakage of radioactive material in whole-body imaging. The mean frequency of CA in lymphocytes determined prior to the onset of therapy (0.31 +/- 0.48/900 cells) was not significantly increased, in comparison to the control values obtained 2 (0.30 +/- 0.48/900 cells) and 90 days (0.15 +/- 0.37/900 cells) after radiosynovectomy (p = 1.0 and 0.625, respectively). We observed that MN frequency was mildly increased in lymphocytes 2 days after therapy (8.30 +/- 1.89 MN/1000 binucleated cells vs. 9.23 +/- 1.79 MN/1000 binucleated cells; p = 0.013). But there was no significant difference between the baseline and the day 90 control levels of MN (p = 0.196). In the analysis of SCE frequency, there were no significant differences between the baseline (8.11 +/- 0.77) and the control analysis performed 2 and 90 days following radiosynovectomy (8.18 +/- 0.77 and 8.07 +/- 0.74; p = 0.710 and 0.662, respectively). Conclusions: The results of this study indicated that high radiation doses are not obtained by peripheral lymphocytes of children who undergo Y-90 radiosynovectomy and, therefore, they contradict a high cancer risk.
dc.language.isoeng
dc.subjectReviews and References (medical)
dc.subjectPharmacology (medical)
dc.subjectResearch and Theory
dc.subjectRadiology, Nuclear Medicine and Imaging
dc.subjectRadiological and Ultrasound Technology
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectOncology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectNükleer Tıp
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.titleThe genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid
dc.typeMakale
dc.relation.journalCANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
dc.contributor.department, ,
dc.identifier.volume22
dc.identifier.issue3
dc.identifier.startpage393
dc.identifier.endpage399
dc.contributor.firstauthorID12990


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster